Chewy, Inc. current report, 18 January 2024

Full document

Chewy, Inc. Form 8-K Summary

Business Context and Reporting Period

Chewy filed this Current Report on January 18, 2024, under Item 8.01, to provide recast historical financial information following transactions with affiliates of BC Partners Advisors LP. The transactions resulted in Chewy Pharmacy KY, LLC becoming an indirect wholly owned subsidiary of Chewy.

The recast information covers previously reported periods, including fiscal years ended January 30, 2022 and January 29, 2023, and quarterly periods ended April 30, July 30, and October 29, 2023.

Financial Metrics and Recast Information

The filing provides no clear revenue, profit, cash flow, margin, debt, liquidity, or other numerical financial values in the supplied text. Exhibit 99.1 contains recast historical unaudited condensed consolidated financial information reflecting Chewy Pharmacy KY’s operations, including recast non-GAAP measures.

Material Changes Versus Prior Comparable Period

  • The historical financial information is being recast to include Chewy Pharmacy KY’s operations in Chewy’s consolidated results.
  • The filing states that the recast information does not constitute a restatement of previously issued financial statements.
  • The filing does not describe specific changes in reported revenue, earnings, cash flow, margins, or balance-sheet metrics.

Guidance, Outlook, Risks, and Unusual Items

  • No new financial guidance or operating outlook is provided.
  • The filing states that it does not reflect events occurring after the filing dates of the prior reports, except as otherwise reflected in Exhibit 99.1.
  • Investors should review the accompanying prior filings and Exhibit 99.1 for the scope and effect of the recast information and the definitions of the recast non-GAAP measures.

Key Facts for Investors to Verify

  • Verify the transaction terms and the date on which Chewy Pharmacy KY became an indirect wholly owned subsidiary.
  • Review Exhibit 99.1 for the quantitative impact of including Chewy Pharmacy KY in historical consolidated results.
  • Compare the recast figures with the originally reported figures in the 2021 Form 10-K, 2022 Form 10-K, and 2023 Form 10-Qs.
  • Confirm the reconciliation and presentation of recast non-GAAP financial measures.
  • Note that the filing expressly states the recast information is not a restatement of previously issued financial statements.